Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy
UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.